Clinical Trial

Patient Journey in Advanced Gynecologic Cancers

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 11, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a mixed-methods survey study including a 2-phased sequential-explanatory design. This study is to understand the patient journey in conventional therapy for newly diagnosed stage III or IV CC or EC in China, including ①patients' treatment decision making factors and treatment experiences and ② patients' unmet needs during post-treatment surveillance.
Trial Details
NCT Number NCT07015593
Lead Sponsor Tongji Hospital
Conditions Genital Neoplasms, Female, Uterine Cervical Neoplasms, Endometrial Carcinoma
Enrollment 780 participants
Start Date 2025-07-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-11